Tarsus Pharmaceuticals, Inc. (TARS)

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 5 signals for Tarsus Pharmaceuticals, Inc.. Most notable: 2026-09-10: Filed 8-K disclosing acquisition or disposition of assets; 2026-07-13: Filed 8-K disclosing director or officer change; 2026-07-08: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing acquisition or disposition of assets
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing material agreement
  4. Material 8-K filing
    Filed 8-K disclosing director or officer change
  5. Material 8-K filing
    Filed 8-K disclosing material agreement
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-09-15LINK WILLIAM J PHDdirectorS6680.01$5,281
2026-09-15LINK WILLIAM J PHDdirectorS75979$59,961
2026-09-15LINK WILLIAM J PHDdirectorS11,67578.33$914,503
2026-09-15LINK WILLIAM J PHDdirectorM201
2026-09-15YARNO WENDY LdirectorM302
2026-09-15PYOTT DAVID E IdirectorM201
2026-09-04Neervannan SeshadriofficerS4,56485$387,940
2026-09-04Lin Elizabeth YeuofficerS1,59090$143,100
2026-09-04Lin Elizabeth YeuofficerS1,59085$135,150
2026-09-04Lin Elizabeth YeuofficerS5,38690$484,740
2026-09-04Lin Elizabeth YeuofficerS5,38785$457,895
2026-09-04Azamian Bobak R.directorS2,90091.27$264,683
2026-09-04Azamian Bobak R.directorS7,10090.27$640,917
2026-09-02Azamian Bobak R.directorS10,00080.06$800,600
2026-09-02Lin Elizabeth YeuofficerS5,38780$430,960
2026-09-02Lin Elizabeth YeuofficerS1,59080$127,200
2026-09-01Lin Elizabeth YeuofficerS4,60173.86$339,830
2026-06-17Azamian Bobak R.directorS5,41861.81$334,887
2026-06-17Azamian Bobak R.directorS4,58261.24$280,602
2026-06-17Azamian Bobak R.directorS4,58261.24$280,602
2026-06-17Azamian Bobak R.directorS5,41861.81$334,887
2026-06-16Farrow Jeffrey SofficerS14,39660.95$877,436
2026-06-16Farrow Jeffrey SofficerS14,39660.95$877,436
2026-06-15Farrow Jeffrey SofficerM27,881
2026-06-15Goodrich KatherinedirectorS2,95462.08$183,384
2026-06-15LINK WILLIAM J PHDdirectorS10,57261.97$655,147
2026-06-15LINK WILLIAM J PHDdirectorS1,92862.94$121,348
2026-06-15Farrow Jeffrey SofficerM27,881
2026-06-15Goodrich KatherinedirectorS2,95462.08$183,384
2026-06-15LINK WILLIAM J PHDdirectorS10,57261.97$655,147
2026-06-15LINK WILLIAM J PHDdirectorS1,92862.94$121,348
2026-06-12Morrison Scott WdirectorM2,954
2026-06-12LINK WILLIAM J PHDdirectorM2,954
2026-06-12CHAUDHURI BHASKARdirectorM2,954
2026-06-12Goodrich KatherinedirectorM2,954
2026-06-12YARNO WENDY LdirectorM2,954
2026-06-12Goldberg Andrew D.directorM2,954
2026-06-12Morrison Scott WdirectorM2,954
2026-06-12LINK WILLIAM J PHDdirectorM2,954
2026-06-12CHAUDHURI BHASKARdirectorM2,954
2026-06-12Goodrich KatherinedirectorM2,954
2026-06-12YARNO WENDY LdirectorM2,954
2026-06-12Goldberg Andrew D.directorM2,954
2026-04-24PYOTT DAVID E IdirectorM1,383
2026-04-24PYOTT DAVID E IdirectorM1,383
2026-03-20Neervannan SeshadriofficerS2,98966.75$199,516
2026-03-20Neervannan SeshadriofficerS2,98966.75$199,516
2026-03-19Whitfield Dianne C.officerS4,17467$279,658
2026-03-19Wahl BryanofficerS4,23167$283,477
2026-03-19Neervannan SeshadriofficerS4,58967$307,463

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

  • 2026-09-17 4
  • 2026-09-17 4
  • 2026-09-17 4
  • 2026-09-15 144
  • 2026-09-10 8-K
  • 2026-09-09 4
  • 2026-09-09 4
  • 2026-09-09 4
  • 2026-09-04 144
  • 2026-09-04 144
  • 2026-09-04 144
  • 2026-09-04 144
  • 2026-09-03 4
  • 2026-09-03 4
  • 2026-09-02 144
  • 2026-09-02 144
  • 2026-09-02 144
  • 2026-09-02 144
  • 2026-09-01 144
  • 2026-09-01 144
Tarsus Pharmaceuticals, Inc. (TARS): insider trades, federal contracts, lobbying | IP Files